(SeaPRwire) – By: Ethan Gallagher
Here is what nobody repeated after the earnings call. ASML customers are placing orders for 2029 and 2030. Christophe Fouquet stood at the podium and said planned supply for 2027 and 2028 will not fully meet demand. He said the company is exploring ways to go beyond its planned 30% capacity increase in 2028. He did not say how. No European lithography equipment maker has ever executed a 30% capacity ramp on schedule, let alone beyond it. Optical systems. Laser sources. Precision stage motors. Every component sits behind a multi-year supply chain that does not open for negotiation. The stock rose 1.6% in premarket. Wall Street heard “third guidance increase” and tuned out “we cannot physically build enough units.” Those are two different stories. Only one of them holds when 2028 arrives.
The company raised 2026 net sales guidance to €44 billion to €45 billion. That is the third adjustment this year. Q3 net sales hit €11.66 billion. Net income reached €4.96 billion. Analysts had penciled in €4.13 billion. Gross margin expanded to 57.5% from 54%. Full-year margin guidance sits around 56%. Fouquet confirmed customers keep raising equipment demand forecasts. He tied it to the scale and duration of AI-related investments.
Strip the revenue lines and look at what is actually moving. Jefferies said the 2027 and 2028 increase was broadly expected. They see sector multiples contracting further. The stock gaining 1.6% on the news is not a repricing event. It is a confirmation of consensus. Didier Scemama at BofA caught what the revenue table hides. He estimates a 5% rise in average selling prices could lift earnings per share gains to around 10%. That is the variable that matters. Demand has never been ASML’s constraint. Pricing power is. The company holds a single point of leverage over the entire semiconductor manufacturing stack. TSMC needs EUV. Samsung needs EUV. Intel needs EUV. They are all in the same room and none of them can walk. When a supplier’s customer list shrinks to two names, pricing is not a negotiation. It is a menu. ASML has never had that kind of leverage before, and no one on the street is modeling what happens when it gets exercised.
ASML expects China to make up about 20% of 2026 sales. It made the same forecast for 2025 and ended up near one third. That miss was 50%. CFO Roger Dassen called the proposed Match Act a bad idea. He said it would speed up China’s own domestic technology work. The bill would ban DUV lithography sales to China and cut off servicing for machines already installed there. China accounts for roughly 70% of ASML’s DUV immersion unit sales by volume in recent years.
Read that number again. 70%. If the Match Act passes, ASML loses nearly three-quarters of its DUV immersion revenue overnight. That is not a tailwind risk. That is a revenue cliff. Dassen’s opposition is not ideological. It is arithmetic. The Match Act is a binary event. If it passes, the 20% China forecast becomes a lower bound and actual sales could fall faster than anyone models. If it fails, ASML keeps selling to the world’s second-largest chip market with no regulatory drag. The asymmetry is enormous. Fouquet’s bullish demand narrative through 2030 assumes China remains open. The entire growth thesis collapses on one congressional vote.
Scemama carries a Buy rating and a $2,915 price target on the ADRs. They traded around $1,703 on Tuesday. That is 70% upside in a market where consensus is “broadly expected.” Either he sees something the market does not, or the market sees something he does not. I have spent years watching hardware supply chains break on promises that sounded certain on earnings calls. The EUV supply chain is not a startup pipeline. It is an industrial system with fixed physics. EUV laser cavities take longer to build than a commercial aircraft program. Zeiss’ optics division cannot print lenses overnight. The real bottleneck is not 2026 guidance. It is whether ASML can translate paper orders into metal by 2028. Until that answer is proven in the supply chain, not in a guidance range, the stock is pricing optimism as fact. The Match Act is a coin flip that no one in the room at Eindhoven wants to talk about on speakerphone.
Author bio: Ethan Gallagher, a Silicon Valley hardware architect and infrastructure strategist with over fifteen years analyzing semiconductor supply chain dynamics, lithography equipment scaling, and the collision between industrial capacity limits and capital market expectations.